Cryoglobulinemic vasculitis: having giant steps; but there are still unanswered questions

Intern Emerg Med. 2021 Jan;16(1):33-35. doi: 10.1007/s11739-020-02481-2. Epub 2020 Sep 4.

Authors

Omer Karadag^{1

2}, Emine Duran^{3

4}

Affiliations

¹ Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey. [email protected].
² Hacettepe University Vasculitis Research Centre, Ankara, Turkey. [email protected].
³ Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.
⁴ Hacettepe University Vasculitis Research Centre, Ankara, Turkey.

PMID: 32888110
DOI: 10.1007/s11739-020-02481-2

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived
Biosimilar Pharmaceuticals*
Calcium Carbonate
Cryoglobulinemia* / complications
Cryoglobulinemia* / diagnosis
Humans
Rituximab
Vasculitis* / diagnosis

Substances

Antibodies, Monoclonal, Murine-Derived
Biosimilar Pharmaceuticals
CT-P10
Rituximab
Calcium Carbonate